CLINICAL_TRIALS
trial_result
· 2019-05-21
Clinical Trial Update: Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA) [Phase 2]
Summary
Phase 2 clinical trial evaluating ranolazine for microvascular angina has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Microvascular Angina | Phase 2 | Status: COMPLETED | Results posted: 2019-05-21